ReVision Optics to Continue Enrollment of Phase 3 Trial of the Raindrop Near Vision Inlay
ReVision Optics, Inc., has received conditional approval
from the FDA to continue and complete enrollment in its
phase 3 clinical trial of the Raindrop Near Vision Inlay (formerly
the PresbyLens), according to a news release. The
prospective, multicenter trial is evaluating the safety and
effectiveness of the patented,...